Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $10,000 | 1 | 68.6% |
| Consulting Fee | $3,375 | 2 | 23.1% |
| Food and Beverage | $1,062 | 22 | 7.3% |
| Education | $147.00 | 3 | 1.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bridge to Life Ltd | $10,000 | 1 | $0 (2019) |
| Jazz Pharmaceuticals Inc. | $2,870 | 1 | $0 (2020) |
| Ethicon US, LLC | $578.28 | 5 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $213.14 | 2 | $0 (2024) |
| Veloxis Pharmaceuticals, Inc. | $204.52 | 2 | $0 (2018) |
| La Jolla Pharmaceutical Company | $147.00 | 3 | $0 (2020) |
| Davol Inc. | $141.38 | 1 | $0 (2017) |
| Biocompatibles, Inc. | $112.10 | 1 | $0 (2017) |
| CSL Behring | $80.19 | 1 | $0 (2017) |
| Organ Recovery Systems, Inc. | $51.71 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $235.77 | 3 | SANOFI-AVENTIS U.S. LLC ($213.14) |
| 2022 | $56.71 | 3 | GENZYME CORPORATION ($39.39) |
| 2021 | $536.34 | 3 | Ethicon US, LLC ($536.34) |
| 2020 | $3,033 | 5 | Jazz Pharmaceuticals Inc. ($2,870) |
| 2019 | $10,053 | 4 | Bridge to Life Ltd ($10,000) |
| 2018 | $321.70 | 6 | Veloxis Pharmaceuticals, Inc. ($204.52) |
| 2017 | $348.05 | 4 | Davol Inc. ($141.38) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/23/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/02/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Food and Beverage | In-kind items and services | $94.68 | General |
| Category: Oncology | ||||||
| 01/24/2024 | SANOFI-AVENTIS U.S. LLC | THYMOGLOBULIN (Biological) | Food and Beverage | In-kind items and services | $118.46 | General |
| Category: Oncology | ||||||
| 11/03/2022 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Neurology | ||||||
| 04/14/2022 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Neurology | ||||||
| 04/14/2022 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: IMMUNOLOGY | ||||||
| 10/20/2021 | Ethicon US, LLC | Echelon; Endopath (Device), Echelon Flex | Consulting Fee | Cash or cash equivalent | $505.00 | General |
| Category: Endo-Mechanical | ||||||
| 09/21/2021 | Ethicon US, LLC | Harmonic (Device) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: Energy | ||||||
| 01/20/2021 | Ethicon US, LLC | Echelon; Endopath (Device), ETHICON | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Endo-Mechanical | ||||||
| 06/11/2020 | Ethicon US, LLC | Surgicel Powder (Device) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Biosurgical | ||||||
| 03/30/2020 | Jazz Pharmaceuticals Inc. | DEFITELIO (Drug) | Consulting Fee | Cash or cash equivalent | $2,870.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 01/31/2020 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Education | In-kind items and services | $51.00 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 01/31/2020 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Education | In-kind items and services | $48.00 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 01/23/2020 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Education | In-kind items and services | $48.00 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 07/31/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $11.13 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 06/26/2019 | Incyte Corporation | — | Food and Beverage | Cash or cash equivalent | $24.61 | General |
| 05/08/2019 | E.R. Squibb & Sons, L.L.C. | NULOJIX (Biological) | Food and Beverage | Cash or cash equivalent | $17.08 | General |
| Category: Immunology | ||||||
| 01/19/2019 | Bridge to Life Ltd | — | — | Stock, stock option, or any other ownership interest | $10,000.00 | Research |
| Study: Papain | ||||||
| 12/07/2018 | Baxter Healthcare | FLOSEAL (Biological) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Surgical Care | ||||||
| 11/28/2018 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $183.72 | General |
| Category: Immunosuppressant | ||||||
| 11/28/2018 | Veloxis Pharmaceuticals, Inc. | Envarsus XR (SP) (Drug), Envarsus XR, Envarsus XR | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Immunosuppressant | ||||||
| 05/01/2018 | Novartis Pharmaceuticals Corporation | ZORTRESS (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: IMMUNOLOGY | ||||||
| 01/12/2018 | Organ Recovery Systems, Inc. | — | Food and Beverage | Cash or cash equivalent | $51.71 | General |
| 01/10/2018 | Ethicon US, LLC | PROLENE Polypropylene Suture (Device) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: Sutures | ||||||
| 12/11/2017 | Biocompatibles, Inc. | THERASPHERE - BIO (Device) | Food and Beverage | In-kind items and services | $112.10 | General |
| Category: INTERVENTIONAL ONCOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Papain | Bridge to Life Ltd | $10,000 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 61 | 93 | $199,370 | $42,432 |
| 2021 | 3 | 65 | 151 | $34,144 | $13,930 |
| 2020 | 4 | 118 | 238 | $53,004 | $20,399 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 50360 | Transplantation of donor kidney | Facility | 2023 | 17 | 17 | $138,210 | $30,153 | 21.8% |
| 50605 | Insertion of stent in ureter | Facility | 2023 | 18 | 18 | $51,120 | $7,083 | 13.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 42 | $5,880 | $2,781 | 47.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 16 | $4,160 | $2,416 | 58.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 20 | 101 | $21,614 | $8,298 | 38.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 31 | 36 | $8,568 | $4,115 | 48.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 14 | 14 | $3,962 | $1,516 | 38.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 40 | 130 | $27,820 | $10,895 | 39.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 39 | 64 | $15,232 | $5,683 | 37.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 24 | 24 | $6,792 | $2,619 | 38.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 15 | 20 | $3,160 | $1,201 | 38.0% |
About Kenneth Chavin, MD, PHD
Kenneth Chavin, MD, PHD is a Transplant Surgery healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801901731.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kenneth Chavin, MD, PHD has received a total of $14,584 in payments from pharmaceutical and medical device companies, with $235.77 received in 2024. These payments were reported across 28 transactions from 19 companies. The most common payment nature is "" ($10,000).
As a Medicare-enrolled provider, Chavin has provided services to 244 Medicare beneficiaries, totaling 482 services with total Medicare billing of $76,761. Data is available for 3 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Transplant Surgery
- Other Specialties Surgery
- Location Philadelphia, PA
- Active Since 08/20/2006
- Last Updated 09/28/2022
- Taxonomy Code 204F00000X
- Entity Type Individual
- NPI Number 1801901731
Products in Payments
- DEFITELIO (Drug) $2,870
- Echelon; Endopath (Device) $524.64
- THYMOGLOBULIN (Biological) $213.14
- Envarsus XR (SP) (Drug) $204.52
- GIAPREZA (Drug) $147.00
- DAV-Phasix (Device) $141.38
- THERASPHERE - BIO (Device) $112.10
- Product in Development (Biological) $80.19
- AUBAGIO (Drug) $39.39
- PROLENE Polypropylene Suture (Device) $26.25
- ZORTRESS (Drug) $24.33
- PREVYMIS (Drug) $22.63
- LIVTENCITY (Drug) $17.32
- NULOJIX (Biological) $17.08
- Surgicel Powder (Device) $15.69
- FLOSEAL (Biological) $14.89
- PICO (Device) $14.38
- Harmonic (Device) $11.70
- ACTHAR (Biological) $11.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Transplant Surgery Doctors in Philadelphia
Dr. Adam Bodzin, M.d, M.D
Transplant Surgery — Payments: $118,715
James Markmann, Md, MD
Transplant Surgery — Payments: $95,323
Kenneth Margulies, Md, MD
Transplant Surgery — Payments: $32,615
Dr. Antonio Di Carlo, Md, MD
Transplant Surgery — Payments: $12,920
Dr. Kwan Nang Lau, M.d, M.D
Transplant Surgery — Payments: $12,442
Gary Xiao, Md, MD
Transplant Surgery — Payments: $11,083